Differential effects of nitroblue tetrazolium on the hemodynamic responses elicited by activation of α1-adrenoceptors and 5-HT2 receptors in conscious rats

European Journal of Pharmacology

Volumn 535, Issue 1-3, 2006, Pages 248-252

  Owen, Joy R ^a   Bates, James N ^b   Lewis, Stephen J ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

1 adrenoceptor; (Rat); 5 HT2 receptor; Hemodynamics; Nitroblue tetrazolium

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA METHYLSEROTONIN; NITROBLUE TETRAZOLIUM; SEROTONIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HEMODYNAMICS; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ADRENERGIC ALPHA-ANTAGONISTS; AMIDINES; ANIMALS; BLOOD PRESSURE; CONSCIOUSNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INDICATORS AND REAGENTS; INJECTIONS, INTRAVENOUS; MALE; NITROBLUE TETRAZOLIUM; PHENYLEPHRINE; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; VASCULAR RESISTANCE;

EID: 33645418687     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.01.060     Document Type: Article

References (35)

1. F.P. Altman On the oxygen-sensitivity of various tetrazolium salts Histochemie 22 1970 256 261
2. F.P. Altman Studies on the reduction of tetrazolium salts. III. The products of chemical and enzymatic reduction Histochemistry 38 1974 155 171
3. F.P. Altman Tetrazolium salts and formazans Prog. Histochem. Cytochem. 9 1976 1 56
4. W.W. Batenburg, R. de Vries, P.R. Saxena, and A.H. Danser l-S-nitrosothiols: endothelium-derived hyperpolarizing factors in porcine coronary arteries? J. Hypertens. 22 2004 1927 1936
5. J.S. Beckman, T.W. Beckman, J. Chen, P.A. Marshall, and B.A. Freeman Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide Proc. Natl. Acad. Sci. U. S. A. 87 1990 1620 1624
6. N.A. Benkusky, S.J. Lewis, and N.W. Kooy Attenuation of vascular relaxation after development of tachyphylaxis to peroxynitrite Am. J. Physiol. 275 1998 H501 H508
7. N.A. Benkusky, S.J. Lewis, and N.W. Kooy Peroxynitrite-mediated attenuation of α- and β-adrenoceptor agonist-induced vascular responses in vivo Eur. J. Pharmacol. 364 1999 151 158
8. 2- radicals J. Phys. Chem. 84 1980 830 833
9. 3-adrenoceptors and atrial receptors mediating tachycardia Br. J. Pharmacol. 126 1999 1018 1024
10. R.L. Davisson, T.M. Walton, A.K. Johnson, and S.J. Lewis Cardiovascular effects produced by systemic injections of nitro blue tetrazolium (NBT) in the rat Eur. J. Pharmacol. 241 1993 135 137
11. R.L. Davisson, M.D. Travis, J.N. Bates, and S.J. Lewis Hemodynamic effects of l- and d-S-nitrosocysteine in the rat: stereoselective S-nitrosothiol recognition sites Circ. Res. 79 1996 256 262
12. R.L. Davisson, R.A. Shaffer, A.K. Johnson, and S.J. Lewis Use-dependent loss of active sympathetic neurogenic vasodilation following NO synthase inhibition in conscious rats: evidence for the presence of preformed stores of nitric oxide-containing factors Hypertension 28 1996 347 353
13. 3- adrenoceptor: the search for a physiological function Trends Pharmacol. Sci. 15 1994 3 7
14. G.H. Findlay The value of some tetrazolium salts as histochemical reagents for sulphydryl groups J. Histochem. Cytochem. 3 1955 331 338
15. T.K. Harden Agonist-induced desensitization of the β-adrenergic receptor-linked adenylate cyclase Pharmacol. Rev. 35 1983 5 32
16. N.K. Hollenberg Serotonin and vascular responses Annu. Rev. Pharmacol. Toxicol. 28 1988 41 59
17. A. Hoque, J.N. Bates, and S.J. Lewis Redox regulation of S-nitrosocysteine-mediated vasodilation in vivo Eur. J. Pharmacol. 408 2000 195 198
18. D. Julius Molecular biology of serotonin receptors Annu. Rev. Neurosci. 14 1991 335 360
19. --channels in alpha-adrenoceptor-mediated vasoconstriction in the anesthetized rat Eur. J. Pharmacol. 401 2000 403 412
20. S.J. Lewis, A. Hoque, and J.N. Bates Differentiation of l- and d-S-nitrosothiol recognition sites J. Cardiovasc. Pharmacol. 46 2005 660 671
21. S.J. Lewis, A. Hoque, T.M. Walton, and N.W. Kooy Potential role of nitration and oxidation reactions in the effects of peroxynitrite on the function of β-adrenoceptor sub-types in the rat Eur. J. Pharmacol. 518 2005 187 194
22. 3 receptor subtypes Brain Res. 561 1991 61 68
23. S.T. Meller, S.J. Lewis, M.J. Brody, and G.F. Gebhart Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes Brain Res. 585 1992 71 86
24. S. Moncada, E.A. Higgs, and E.A. Palmer Nitric oxide: physiology, pathophysiology and pharmacology Pharmacol. Rev. 43 1991 109 142
25. P.R. Myers, R. Minor Jr., R. Guerra Jr., J.N. Bates, and D.G. Harrison Vasorelaxant properties of the endothelium-derived relaxing factor more closely resembles S-nitrosocysteine than nitric oxide Nature 345 1990 161 163
26. W.C. Probst, L.A. Snyder, D.I. Schuster, J. Brosius, and S.C. Sealfon Sequence alignment of the G-protein coupled receptor superfamily DNA Cell Biol. 11 1992 1 20
27. R. Radi, J.S. Beckman, K.M. Bush, and B.A. Freeman Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide J. Biol. Chem. 266 1991 4244 4250
28. W.I. Rosenblum Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide Stroke 23 1992 1527 1535
29. E. Seidler The tetrazolium-formazan system: design and histochemistry Prog. Histochem. Cytochem. 24 1991 1 86
30. E. Seidler, and J.F. van Noorden On the mechanism of the multistep reduction of tetrazolium salts with special reference to the involvement of tetrazolium radicals Acta Histochem. 96 1994 43 49
31. 2+-channels markedly diminishes nitric oxide-but not l-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo Eur. J. Pharmacol. 408 2000 289 298
32. 2-receptors Eur. J. Pharmacol. 382 1999 207 210
33. E.J. Whalen, A.K. Johnson, and S.J. Lewis β-adrenoceptor dysfunction after inhibition of NO synthesis Hypertension 36 2000 376 382
34. 1- adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of the rat Br. J. Pharmacol. 114 1995 531 536
35. E. Zifa, and G. Fillion 5-hydroxytryptamine receptors Pharmacol. Rev. 44 1992 401 458